Inaugural JAX-NYSCF Gala ushers a new era for global human health research
By Lisa Nichols
Article | November 19, 2026
The Jackson Laboratory convened its newly expanded community in New York last week for the inaugural JAX-NYSCF Gala, the first since JAX and The New York Stem Cell Foundation (NYSCF) joined forces in 2025 to accelerate discoveries and bring promising therapies closer to patients. The theme, “Stronger together: From lab to life,” celebrated the power of connections that turn research into real-world impact.
“This is the most exciting time in the history of biomedicine, and you’re all here for it,” said JAX President and CEO Lon Cardon, referring to the unprecedented breadth and depth of research made possible by JAX and NYSCF’s complementary strengths in mouse, human stem cell and computational models for disease.
Honoring innovation and advocacy
Previously hosted by NYSCF, the gala has a 20-year history of bringing together leaders in science, medicine, business and design who share a passion for scientific research. In keeping with tradition, the evening recognized three longstanding members of the JAX-NYSCF community: Honorary JAX-NYSCF Scientist Martha Stewart for her commitment to innovation in health and the science of living well; and Pioneering Patient Advocates JAX Trustee Dinakar Singh and his daughter Arya Singh—early partners with JAX in Arya’s diagnosis of spinal muscular atrophy—for their championing of patients and families living with rare disease.
Emmy®, Golden Globe and Tony Award-winning actor and singer Darren Criss—a longtime family friend of the Singhs—made a special video appearance to present their award. New York attorney Andy Nussbaum, a longtime family friend of Stewart and supporter of NYSCF, presented her award.
The evening was chaired by renowned fashion designer and JAX Trustee Kay Unger, who formerly served on the NYSCF Board and was a 2023 NYSCF Gala honoree.
Science Fair features groundbreaking research
More than 30 scientists represented JAX’s research expertise at the Science Fair, an immersive, interactive experience that has accompanied the gala since its inception. JAX’s world-leading researchers shared a firsthand look at programs spanning neurodegenerative conditions, aging, rare disease, cancer and cardiovascular health in the context of drug development, and how discoveries in these areas connect to patients’ experiences.
Stronger together: A unified vision for the future
Several research programs featured at the Science Fair originated at NYSCF and have accelerated to the next phase through partnerships and scientific resources that JAX uniquely provides. In turn, the NYSCF Global Stem Cell Array®, a pioneering robotic platform that enables unprecedented large-scale, reproducible stem cell research, brings crucial new insights to JAX’s expertise in disease modeling.
Founding NYSCF Board Chair and current JAX Trustee Roy Geronemus reflected upon the impact and potential of NYSCF and JAX coming together. “Many important organizations reach a point where, in an effort to expand their scope and nurture their projects, a partnership with a powerful, larger, visionary organization makes sense,” Geronemus said. “With this union, the potential to accelerate scientific and medical treatments and cures will reach new heights.”
Executive Vice President and Chief Scientific Officer Mary Dickinson drew on a well-known proverb to echo the visionary path set forward for the future of health, closing the evening with an invitation to help JAX move discoveries out of the lab and into the clinic faster than ever before.
“If you want to go fast, you go alone. If you want to go far, you go together. If you want to do both, Dickinson concluded, “come with us.”
Meet our honorees
Martha Stewart
With a home near JAX’s Bar Harbor headquarters, Martha Stewart has long admired JAX’s leadership in scientific research and toured the campus last summer upon hearing that JAX and NYSCF had come together. She was an early supporter of late founder Susan Solomon’s vision for NYSCF and brought crucial visibility to the organization by having Solmon as a guest on her talk show.
Dinakar and Arya Singh
When Arya was diagnosed with spinal muscular atrophy (SMA) at 18 months, there were no approved treatments. Working with scientists, including JAX researchers, Dinakar helped advance SMA research that ultimately lead to the first FDA-approved treatment for SMA. Today, as chair of the SMA Foundation and a JAX Trustee, he continues to champion more effective and accessible drug development for families facing rare diseases.
Now 25, Arya is a force for change in the public health field, channeling her experience into advocacy for children with rare diseases and chronic illnesses. In Washington, D.C., she has testified before Congress and met with top advisors about rare disease legislation. She has also spoken at rare disease conferences around the country.